A Study of Vemurafenib and Obinutuzumab Compared to Cladribine and Rituximab in People With Hairy Cell Leukemia (HCL)
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
Genmab
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Scripps Health
University of Giessen
Barbara Ann Karmanos Cancer Institute
Wake Forest University Health Sciences
Fred Hutchinson Cancer Center
Masonic Cancer Center, University of Minnesota
Fred Hutchinson Cancer Center
Mayo Clinic
Rutgers, The State University of New Jersey
National Cancer Institute (NCI)
Swiss Cancer Institute